[1] Harz S Conjeevaram, Anna S Lok. Occult hepatitis B virus infection: A hidden manace?[J].Hepatology, 2001, 34 (1) ∶204-206.
|
[2] Sagnelli E, Coppola N, Scolastico C, et al. HCV genotype and “silent” HBV coinfection: two main risk factors for a more severe liver disease[J]. J Med Virol, 2001, 64 (3) ∶350-5.
|
[3] Christian B, Valerie. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely “occult”?[J].Hepatology, 2001, 34 (1) 194-203.
|
[4] Zhangyongyuan. Hepatitis B virus DNA in serum and liver is commonly found in chinese patients with chronic liver disease despite the presence of antibodies to HBsAg[J].Hepatology, 1993, 17∶538.
|
[5] Lili Kazemi-Shirazi, Dagmar Petermann. Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C[J].Journal of hepatology, 2000, 33∶785-790.
|
[6]Liaw YF, Lin SM, Sheen IS, et al. Acute hepatitis C virus superinfection followed by spontaneous HBeAg seroconversion and HBsAg elimination[J].Infection, 1991, 19∶250-251.
|
[1] | Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association, Chinese Society of Perinatal Medicine, Chinese Medical Association. 2020 clinical guidelines on prevention of mother-to-child transmission of hepatitis B virus[J]. Journal of Clinical Hepatology, 2020, 36(7): 1474-1481. doi: 10.3760/cma.j.cn112141-20200213-00101 |
[2] | Zhang WenJie, Li ChaoXia, Tian ShuJu, Mao WeiWu, Gong YanXuan, Qu Yan. Generation of neutralizing anti-interferon antibodies and its influence on the interferon-alpha (IFN-alpha) treatment for chronic hepatitis C[J]. Journal of Clinical Hepatology, 2010, 26(1): 27-30. |
[3] | Zhou XianShan, Hong HuiLan. Clinical analysis of elderly patients with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2008, 24(5): 364-366. |
[4] | Su Zheng, Yao XiXian, Wang JunMin, Bai WenYuan, Zhang XinYuan. The relationship between the levels of serum IL-4 and IFN-γ and influence factors of anti-viral therapy for patients with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2007, 23(3): 185-186. |
[5] | Xie Fang, Lin ZunHui, Jin HaiYing, Guo XiangHua, Huang YanXiang, Yin JiMing, Yan Yan, Hao Wa, Niu JingQin, Li Zhuo. The applied value of Dane granule antigen of hepatitis B viral in detecting chronic hepatitis B infection[J]. Journal of Clinical Hepatology, 2007, 23(6): 415-417. |
[6] | Guo HaiYan, Chen Ming, Wang LiPing, Ge GuoHong, Zhang YanChao. Recent thymic output function in patients with chronic hepatitis C by real time fluorescence quantitative PCR analysis[J]. Journal of Clinical Hepatology, 2007, 23(6): 432-433. |
[7] | Pei Bin, Chen ZhangRong, Huang WenQi, Xie JinZhen. The change of Th1/Th2 cytokines expression in treatment of chronic hepatitis C with IFN-α and ribavirin[J]. Journal of Clinical Hepatology, 2006, 22(3): 188-190. |
[9] | Jiao Jian, Wang JiangBin. Association between HLA-DRB and chronic hepatitis C infection and its effect on the response to interferon alpha and ribavilin therapy[J]. Journal of Clinical Hepatology, 2004, 20(6): 329-331. |
[12] | Shao ChunZhong, Chen XiaoXia, Yuan XiXia, Su Jing, Zheng JunMei, Li Ying. Observation on the effect of α-2b interferon and ribavirin and thymus peptide joint treatment for the 30 patients with chronic hepatitis C.[J]. Journal of Clinical Hepatology, 2002, 18(3): 183-184. |
[14] | Gu XiaoHong, Li QiFen. Study on the Expression of HDAg and HBsAg/HBcAg in Liver Tissues of the Patients with Hepatitis D[J]. Journal of Clinical Hepatology, 2001, 17(1): 20-22. |